No Data
No Data
Yifeng Pharmacy Chain Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Yifeng Pharmacy 2024 Semi-Annual Report
Summary of Yifeng Pharmacy\'s 2024 Semi-Annual Report
Yifeng Pharmacy Chain (603939.SH) has released its half-yearly performance report, with a net income of 0.798 billion yuan, a year-on-year growth of 13.13%.
Yifeng Pharmacy Chain (603939.SH) disclosed its semi-annual report for 2024, reporting revenue of 1...
Yifeng Pharmacy Chain (603939.SH): The non-net income for the first half of the year was 0.786 billion yuan, a year-on-year increase of 15.77%.
Yifeng Pharmacy Chain (603939.SH) announced its semi-annual report on August 29th. During the reporting period, the company's operational performance continued to grow positively, achieving a total operating income of 11.76 billion yuan, an increase of 9.86% compared to the same period last year. The non-recurring net income attributable to shareholders of the listed company was 0.798 billion yuan before deducting non-recurring items and 7.86 billion yuan after deducting non-recurring items, an increase of 13.13% and 15.77% respectively compared to the same period last year. A cash dividend of 0.25 yuan per share was distributed to all shareholders.
Guolian Securities: The continuous advancement of prescription outflow and the increase in the concentration of retail pharmacies.
With the gradual opening of outpatient services to retail pharmacies, the health insurance bureau has issued multiple documents in recent times to strengthen the management of the use of medical insurance funds by designated retail pharmacies, with the hope of promoting the concentration of market share in pharmacies with stronger compliance awareness.
No Data